Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
During a slow month for diagnostic M&A activity, a noteworthy deal was the closing of Grifols's acquisition of Hologic's blood screening business. The acquired assets include…
From - Laboratory Industry Report
We recently outlined the major effects and the steps you can take to manage the impact of the travel ban executive order…
From - Laboratory Industry Report
Veracyte, Inc. is a leader in developing noninvasive genomic diagnostic tests for lung cancer. And in February, Veracyte's share of this lucrative market grew…
From - Laboratory Industry Report
Late last week, LabCorp and the owners of Pathology Associates Medical Laboratories (known as PAML) announced that LabCorp would acquire ownership of…